DANTROLENE SODIUM Recall D-1080-2022
Description: Revonto (dantrolene sodium for injection), 20 mg/vial, 6-count box, Rx only, MFG: US WorldMeds, Inc., NDC 27505-003-67
DANTROLENE SODIUM Recall D-1080-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-1080-2022 |
| Event ID | 89646 |
| Brand | REVONTO |
| Generic Name | DANTROLENE SODIUM |
| Manufacturer | DANTROLENE SODIUM |
| Original Package? | 1 |
| Active Substance | DANTROLENE SODIUM |
| Drug Route | INTRAVENOUS |
| Distribution | USA nationwide. |
| Quantity | 16 cartons/6 vials each |
| Recall Reason | cGMP deviations: Temperature abuse |
| Drug Classification | Class II |
| Drug Code Info | 20220615 |
| Product NDC | 27505-003 |
| Recall Initiation Date | 20220413 |
| Report Date | 20220615 |
| Classification Date | 20220609 |
| Address | 9954 Maryland DriveDeep Run Iii Ste. 4000 Richmond, VA 23233 United States |
| Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
| Initial Notification | Letter |
| Unique Ingredient Identifier | 287M0347EV |
| Drug Application Number | ANDA078378 |
| Structured Product Labeling (SPL ID) | cfcfad0f-e5e4-bfd6-e053-2995a90a0cef |
| Structured Product Labeling (SPL Set ID) | 78801254-73a0-44ca-9222-7b3581af82d8 |
| Similar To |